IMproved PREdiction of Severe Sepsis in the Emergency Department



Status:Completed
Conditions:Infectious Disease, Hospital
Therapuetic Areas:Immunology / Infectious Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:4/15/2017
Start Date:March 2011
End Date:September 2015

Use our guide to learn which trials are right for you!

Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.

The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used
as a marker of severe sepsis (including septic shock) in patients presenting to the
emergency department with suspected infection.


Inclusion Criteria:

- Greater than or equal to 18 years

- Suspected Infection

- one or more SIRS criteria
We found this trial at
2
sites
1 Cooper Plaza
Camden, New Jersey 08103
(856) 342-2000
Cooper University Hospital Cooper University Health Care, the clinical campus of Cooper Medical School of...
?
mi
from
Camden, NJ
Click here to add this to my saved trials
?
mi
from
Linkoping,
Click here to add this to my saved trials